HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
7,13- bis(4- nitrobenzyl)- 1,4,10- trioxa- 7,13- diazacyclopentadecane
Potassium channel blocker; structure in first source
Also Known As:
VU590
Networked:
1
relevant articles (
0
outcomes,
1
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
7,13-bis(4-nitrobenzyl)-1,4,10-trioxa-7,13-diazacyclopentadecane: 1
Experts
1.
Butt, Arthur M
: 1 article (04/2020)
2.
Lewis, Anthony
: 1 article (04/2020)
3.
Papanikolaou, Maria
: 1 article (04/2020)
Related Diseases
1.
Ischemia
04/01/2020 - "
A key finding of this study is that blockade of Kir7.1 with VU590 compromised oligodendrocyte cell integrity and compounds oligodendroglial loss in ischemia/hypoxia in the oxygen-glucose deprivation (OGD) model in isolated intact optic nerves.
"
2.
Hypoxia (Hypoxemia)
04/01/2020 - "
A key finding of this study is that blockade of Kir7.1 with VU590 compromised oligodendrocyte cell integrity and compounds oligodendroglial loss in ischemia/hypoxia in the oxygen-glucose deprivation (OGD) model in isolated intact optic nerves.
"
Related Drugs and Biologics
1.
Oxygen (Dioxygen)
2.
Glucose (Dextrose)